Reza Ghalehtaki

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

April, 2025

Reza Ghalehtaki

Jan 6, 2025, 14:37 | Science

Felipe Couñago: Outcomes of neoadjuvant chemoradiotherapy in T4 rectal cancer patients

Felipe Couñago, National Clinical Director of GenesisCare Spain, shared a recent article on X: "Our…

Dec 30, 2024, 11:16 | Insight

Filippo Alongi: Analysis of patients with locally advanced rectal cancer given neoadjuvant radiochemotherapy with or without RT dose intensification

Filippo Alongi, Chairman of Advanced Radiation Oncology, shared a post on X: “12 international centres,…

Oct 20, 2024, 12:48 | Insight

Reza Ghalehtaki: TNT is the new standard of care for LARC

Reza Ghalehtaki, Radiation Oncologist at Cancer Institue of Iran, shared a post on X: "Hot…

Sep 25, 2024, 14:42 | Blog

Cathy Eng: Combination of ICI's and radiotherapy in locally advanced GEJ adenocarcinoma

Cathy Eng posted on X about recent paper by Nina N. Sanford as co-author, titled…

All: 4 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023